| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/06/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 59,794 shares
@ $7.2085, valued at
$431k
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 10/05/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $7.2907, valued at
$64.8k
|
|
| 10/04/2023 |
4
| Dar Zavain (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,920 shares
@ $0 |
|
| 10/04/2023 |
4
| CHAVEZ R. MARTIN (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 2,619 shares
@ $0 |
|
| 10/04/2023 |
4
| Li Dean Y (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Granted 1,659 shares
@ $0
Gifted 627,705 shares
@ $0 |
|
| 10/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/02/2023 |
4
| Larson Tina Marriott (President and COO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 3,000 shares
@ $7.7198, valued at
$23.2k
Exercised 3,000 options to buy
@ $1.06, valued at
$3.2k
|
|
| 10/02/2023 |
8-K
| Quarterly results |
| 09/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/24/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 8,885 shares
@ $8.9118, valued at
$79.2k
|
|
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/11/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Converted 10,000 shares
@ $0
Gifted 10,000 shares
@ $0
Converted 10,000 options to buy
@ $0 |
|
| 08/11/2023 |
8-K/A
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 08/10/2023 |
4
| Borgeson Blake (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 14,498 shares
@ $11.0255, valued at
$159.8k
Sold 3,272 shares
@ $11.7468, valued at
$38.4k
|
|
| 08/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/08/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/08/2023 |
424B7
| Form 424B7 - Prospectus [Rule 424(b)(7)]: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits I... |
| 08/04/2023 |
4
| Gibson Christopher (CEO) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.|
Txns:
| Sold 60,955 shares
@ $13.0171, valued at
$793.5k
Sold 4,060 shares
@ $13.3631, valued at
$54.3k
Exercised 8,674 options to buy
@ $11.4, valued at
$98.9k
Exercised 31,250 options to buy
@ $2.48, valued at
$77.5k
|
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|